Crown Aesthetics, a subsidiary of Crown Laboratories and a leader in the dermatologic and aesthetic medical device industry, has announced that its new SkinPen Precision Elite has received FDA clearance. The SkinPen Precision Elite represents the latest advancement in the SkinPen product line, which has been a popular choice for microneedling procedures in the United States since its initial FDA clearance six years ago.
The SkinPen Precision Elite is scheduled for release later this year and will join Crown Aesthetics’ portfolio as a premium offering for aesthetics professionals. The device features several enhancements based on feedback from providers, including an upgraded user experience with an easy-to-install RFID cartridge, improved patient safety features, and a new technology called ActiSine, which powers active retraction. The device also comes with a lifetime warranty, subject to terms and conditions.
Jeff Bedard, Founder and CEO of Crown Laboratories, emphasized the company’s commitment to innovation and maintaining its leadership position in the microneedling category. He noted that the SkinPen Precision Elite is designed to elevate the standard in microneedling, reflecting the company’s ongoing efforts to improve both provider experience and patient outcomes.
Board-Certified Dermatologist Dr. Doris Day praised the SkinPen brand for its dedication to excellence, highlighting the effectiveness of microneedling with SkinPen in promoting collagen production and improving the appearance of acne scars and wrinkles.
The SkinPen Precision Elite is designed for in-office use, offering a minimally invasive treatment that rejuvenates the skin by improving the appearance of facial acne scars and neck wrinkles. The procedure is quick, easy, and requires minimal downtime, making it a convenient option for patients.